Epithelial Barrier in Allergic Diseases
This course is part of the 2017 Virtual Annual Meeting. Want more virtual meeting recordings? Save by ordering the full set!
Session 3304 from the 2017 AAAAI Annual Meeting discusses the Epithelial barrier leakiness that is becoming more and more important in the pathogenesis of allergic diseases with recently published strong evidence in asthma and atopic dermatitis.
AMA PRA Category 1 Credits™: 1.25
CE: 1.25
Target Audience
Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the molecular mechanisms of epithelial barrier regulation by cells and cytokines
- Discuss the role of epithelial barrier in the pathogenesis of atopic dermatitis and possibilities of interventions
- Define the role of epithelial barrier leakiness in asthma and interventions for prevention and treatment
Faculty
Prof. Cezmi A. Akdis, MD FAAAAI
Swiss Institute of Allergy and Asthma Research, Davos, Switzerland
Relevant relationships: None
Dr. Donna Davies, BSc PhD
University of Southampton, Southampton General Hospitalon, Southampton, United Kingdom
Relevant relationships: None
Prof. Natalija Novak, MD
University of Bonn, Bonn, Germany
Relevant relationships: None
Reviewers
Karen Gregory, DNP APRN-BC RRT AE-C
Oklahoma Allergy and Asthma Clinic, Edmond, OK
Relevant relationships: Merck, MEDA and Novartis: speakers bureau
Jon Ramsey, RN
Georgia Asthma Coalition, Albany, GA
Relevant relationships: Genentech: speaker (Xolair); Shire/Baxalta: advisory board
Kristin Sokol, MD
Beth Israel Deaconess Medical Center, Brookline, MA
Relevant relationships: None
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment. Name of employer and job title.
- Financial interests. All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests. All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts. All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests. All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 1.25 Contact Hours.
Medium and Method of Physician Participation for an Enduring Activity
Follow these steps to complete the activity:
- Register for the activity.
- Review the CME Info Page.
- Complete all required components.
- Complete the post-test. You must achieve a score of 70% or higher on post-tests to claim credit.
- Complete the activity evaluation.
- Claim your credits. Enter only the number of credits earned based on your participation in the activity.
- Print or save your certificate.
AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.
Release date
Original release date: June 1, 2017. Valid for credit through May 31, 2019.
Questions
Activity-related questions should be directed to cme@aaaai.org
Available Credit
- 1.25 AttendanceAttendance credit.
- 1.25 CECE credit.
- 1.25 CMECME credit.